Home › Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk
 

Keywords :   


Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk

2014-08-30 03:04:00| Biotech - Topix.net

Takeda Pharmaceuticals and Eli Lilly & Co lost a bid to overthrow a combined $9 billion punitive-damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.

Tags: risk award bid cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
17.05Fewer crackers in Ritz boxes but price remains same
17.05Eastern North Pacific Tropical Weather Outlook
17.05Boeing boss's $33m pay package approved
17.05Heifers and female cows remain hot topic at sale barn
17.05Dutch Boy Paints Introduces Professional Series at Menards
17.05Atlantic Tropical Weather Outlook
More »